Project Number T-PEP-20-675595 Agency/Funding Organization Alzheimer's Association|Tau Consortium Funding Year 2020 View Full Project Details for HDAC6 inhibitors to treat tauopathies: proof of mechanism Research Categorization Primary Disease / Condition Multiple Dementias CADRO Category C. Translational Research and Clinical Interventions 3. Drug Discovery (small molecules and biologics) b. Tau Researcher and Organization Principal Investigator Kranz, Janice Principal Investigator First Name Janice Principal Investigator Last Name Kranz Awardee Organization Eikonizo Therapeutics, Inc. Awardee State Massachusetts Contact PI Country United States Project Detail Funding Opportunity Announcement PA 2020: T-PEP RFA FY Overall Cost $400,000 Funding Organization Agency/Funding Organization Alzheimer's Association|Tau Consortium Program Official Murtishaw, Andrew asmurtishaw@alz.org
